Lupus miliaris disseminatus faciei
Lupus miliaris disseminatus faciei (LMDF) is a rare, chronic, self-limiting dermatosis that primarily affects the face. It was first described in 1878 by the British dermatologist Robert Willan. The condition is characterized by the presence of small, reddish-brown papules on the face, particularly around the eyes and on the cheeks. The exact cause of LMDF is unknown, but it is thought to be a form of granulomatous rosacea or a variant of tuberculosis of the skin.
Etiology[edit | edit source]
The exact cause of LMDF is unknown. Some researchers believe it is a form of granulomatous rosacea, while others believe it is a variant of cutaneous tuberculosis. However, the presence of Mycobacterium tuberculosis has not been consistently demonstrated in affected individuals, and anti-tuberculosis treatments are not consistently effective, suggesting that the condition may not be directly related to tuberculosis.
Clinical Features[edit | edit source]
LMDF is characterized by the presence of small, reddish-brown papules on the face, particularly around the eyes and on the cheeks. The papules are typically 1-2 mm in diameter and may be accompanied by mild itching or burning. The condition is chronic and self-limiting, with symptoms typically resolving on their own within 1-2 years.
Diagnosis[edit | edit source]
Diagnosis of LMDF is typically based on the characteristic clinical features and confirmed by skin biopsy. The biopsy typically shows a granulomatous inflammation in the dermis, with caseation necrosis often present.
Treatment[edit | edit source]
There is no specific treatment for LMDF. The condition is self-limiting and symptoms typically resolve on their own within 1-2 years. In some cases, topical or oral corticosteroids may be used to help manage symptoms. Other treatments that have been used with varying success include antibiotics, isotretinoin, and dapsone.
Epidemiology[edit | edit source]
LMDF is a rare condition. It can affect individuals of any age, but is most commonly seen in adults between the ages of 20 and 40. The condition affects both men and women, but appears to be slightly more common in women.
See Also[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD